Apalutamide-13C-D3
| Product Name | Apalutamide-13C-D3 |
|---|---|
| Alternate Names | Apalutamide Stable Isotopes, Stable Isotopes of Apalutamide |
| CAT No. | CS-CX-00741 |
| CAS No. | 956104-40-8 (Unlabeled) |
| Category | Stable Isotopes |
| Stock | Enquire |
| Mol. Wt. | 481.45 g/mol |
| Mol. For. | C2013CH12D3F4N5O2S |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Apalutamide |
| Therapeutic | Anti-Cancer / Oncology |
| Smileys | O=C(N1C2=CN=C(C#N)C(C(F)(F)F)=C2)C3(CCC3)N(C4=CC(F)=C(C(N[13C]([2H])([2H])[2H])=O)C=C4)C1=S |
| Canonical Smiles | CNC(=O)C1=C(C=C(C=C1)N2C(=S)N(C(=O)C23CCC3)C4=CC(=C(N=C4)C#N)C(F)(F)F)F |
| InchIKey | HJBWBFZLDZWPHF-UHFFFAOYSA-N |
| Inchl | InChI=1S/C21H15F4N5O2S/c1-27-17(31)13-4-3-11(8-15(13)22)30-19(33)29(18(32)20(30)5-2-6-20)12-7-14(21(23,24)25)16(9-26)28-10-12/h3-4,7-8,10H,2,5-6H2,1H3,(H,27,31) |
| IUPAC | 4-[7-[6-cyano-5-(trifluoromethyl)pyridin-3-yl]-8-oxo-6-sulfanylidene-5,7-diazaspiro[3.4]octan-5-yl]-2-fluoro-N-methylbenzamide |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Apalutamide-13C-D3 is a stable isotope-labeled form of Apalutamide, which is a nonsteroidal antiandrogen drug used for the treatment of prostate cancer. Apalutamide-13C-D3 is a deuterium, carbon-13 labeled analog of Apalutamide, which is used for clinical and research purposes. The stable isotope-labeled Apalutamide-13C-D3 is used in pharmacokinetic and pharmacodynamic studies to measure the drug's metabolism, distribution, and elimination in the body.
Apalutamide-13C-D3 is a potent inhibitor of the androgen receptor and works by blocking the binding of androgens to the receptor. This mechanism of action leads to the inhibition of the growth and proliferation of prostate cancer cells. Apalutamide-13C-D3 has shown promising results in clinical trials, which has led to its approval by the FDA for the treatment of non-metastatic castration-resistant prostate cancer.
The chemical formula of Apalutamide-13C-D3 is C21H16D3N3O4 and its molecular weight is 395.43 g/mol. The compound is a white to off-white powder and is stable under normal storage conditions. The compound's purity is greater than 98%, which makes it suitable for use in research and clinical settings.
In conclusion, Apalutamide-13C-D3 is a stable isotope-labeled form of Apalutamide that is used for pharmacokinetic and pharmacodynamic studies. Its mechanism of action involves blocking the androgen receptor, which leads to the inhibition of the growth and proliferation of prostate cancer cells. Its chemical formula and molecular weight make it a highly pure and stable compound for use in clinical and research settings.
Get an Instant Quote
Related Compounds
N-Desmethyl apalutamide 13C2,15N | Apalutamide-d4 | Apalutamide D7 |